* Tabula Rasa HealthCare Inc TRHC.OQ TRHC.O is expected
to show a rise in quarterly revenue when it reports results on
August 7.
* The Moorestown New Jersey-based company is expected to
report
a 22.4% increase in revenue to $88.871 million from $72.6
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. The company's guidance on May
8 2023, for the period ended June 30, was for revenue between
$88.00 million and $90.00 million.
* Refinitiv's mean analyst estimate for Tabula Rasa
HealthCare
Inc is for a loss of 12 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Tabula Rasa
HealthCare Inc is $8.25, above its last closing price
of $7.83.
The company's guidance on May 8 2023 for the period ended June
30 was for Earnings before Interest, Taxes, Depreciation and
Amortization of between USD88 million and USD4.5 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 -0.14 -0.14 -0.02 Beat 85.7
Dec. 31 2023 -0.22 -0.06 -0.05 Beat 23.1
Sep. 30 2022 -0.19 -0.11 -0.26 Missed -132.1
Jun. 30 2022 -0.17 -0.12 -0.25 Missed -111.9
Mar. -0.16 -0.16 -0.22 Missed -40
31 2022
Dec. 31 2021 -0.09 -0.08 -0.09 Missed -14.3
Sep. 30 2021 0.02 0.03 -0.04 Missed -218.5
Jun. 30 2021 0.00 0.00 -0.01 Missed -200.3
This summary was machine generated August 5 at 02:04 GMT. All
figures in US dollars unless otherwise stated